GLP-1 central appetite + reward-cue dampening
GLP-1 central appetite + reward-cue dampening. Receptor pharmacology pathway. Explains the most user-reported phenomenon of semaglutide/tirzepatide therapy: 'food…
Modulators
- semaglutide — activator
- tirzepatide — activator
- liraglutide — activator
- dulaglutide — activator
Sources: PMID:33567185, PMID:35658024, PMID:29617641, PMID:26831302, PMID:25071023